# Buprenorphine

NDC: 0228-3153
Generic name: Buprenorphine
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20150219

FDA application: ANDA090819

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0228-3153"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0228-3153
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03819118-86f6-4329-adaf-4599e7b71f46